Your browser doesn't support javascript.
loading
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.
O'Shaughnessy, Joyce; Sousa, Susana; Cruz, Josefina; Fallowfield, Lesley; Auvinen, Päivi; Pulido, Catarina; Cvetanovic, Ana; Wilks, Sharon; Ribeiro, Leonor; Burotto, Mauricio; Klingbiel, Dirk; Messeri, Dimitri; Alexandrou, Ari; Trask, Peter; Fredriksson, Judy; Machackova, Zuzana; Stamatovic, Ljiljana.
Afiliação
  • O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, 3410 Worth Street, Suite 400, Dallas, TX 75246, USA. Electronic address: Joyce.OShaughnessy@usoncology.com.
  • Sousa S; Department of Medical Oncology, Portuguese Oncology Institute of Porto, Porto, Portugal. Electronic address: susanapalmadesousa@gmail.com.
  • Cruz J; Department of Medical Oncology, Hospital Universitario de Canarias, La Laguna, S/C Tenerife, Spain. Electronic address: jcruzjurado@gmail.com.
  • Fallowfield L; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9RR, UK. Electronic address: l.j.fallowfield@sussex.ac.uk.
  • Auvinen P; Cancer Center, Kuopio University Hospital, Kuopio, Finland. Electronic address: paivi.auvinen@kuh.fi.
  • Pulido C; Hospital da Luz Lisboa, Avenida Lusíada, 100, 1500-650, Lisbon, Portugal. Electronic address: catarina.pulido@hospitaldaluz.pt.
  • Cvetanovic A; Department of Medical Oncology, Medical Faculty Nis and Clinical Centre Nis, Bul.dr Zorana Djindjica 48, 18000, Nis, Serbia. Electronic address: ana.stankovic@yahoo.com.
  • Wilks S; Texas Oncology SA, Hematology/Medical Oncology, 2130 NE Loop 410 Suite 100, San Antonio, TX 78217, USA. Electronic address: sharon.wilks@usoncology.com.
  • Ribeiro L; Centro Hospitalar Universitário Lisboa Norte, Av. Prof. Egas Moniz, 1649-028, Lisbon, Portugal. Electronic address: leonor.ribeiro@chln.min-saude.pt.
  • Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile. Electronic address: mauricioburotto@gmail.com.
  • Klingbiel D; Pharma Development Biometrics, Biostatistics, F. Hoffmann-La Roche Ltd, Hochstrasse 16, CH-4053 Basel, Switzerland. Electronic address: dirk.klingbiel@roche.com.
  • Messeri D; PDG Clinical Operations Oncology, F. Hoffmann-La Roche Ltd, Hochstrasse 16, CH-4053 Basel, Switzerland. Electronic address: dimitri.messeri@roche.com.
  • Alexandrou A; Portfolio Clinical Safety, Product Development Safety, Roche Products Limited, Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, UK. Electronic address: ari.alexandrou@roche.com.
  • Trask P; Patient Centered Outcomes Research, Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: trask.peter@gene.com.
  • Fredriksson J; Global Product Development/Medical Affairs Oncology, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland. Electronic address: judy.fredriksson@roche.com.
  • Machackova Z; Global Product Development/Medical Affairs Oncology, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland. Electronic address: zuzana.machackova@roche.com.
  • Stamatovic L; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia. Electronic address: ljstamat@ncrc.ac.rs.
Eur J Cancer ; 152: 223-232, 2021 07.
Article em En | MEDLINE | ID: mdl-34147014
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante / Preferência do Paciente / Anticorpos Monoclonais Humanizados / Trastuzumab Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante / Preferência do Paciente / Anticorpos Monoclonais Humanizados / Trastuzumab Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article